Regulatory Guidance
FDA releases final guidance on post‑approval manufacturing changes for biosimilar and interchangeable products
The U.S. Food and Drug Administration announced that a final industry guidance titled “Post‑approval Manufacturing Changes to Biosimilar and Interchangeable Biosimilar Products: Questions and Answers” is now available.…
1 source3 claims checked1h ago
3 unverifiable
Biblical perspectiveINSUFFICIENT CONTEXT
Full analysis